Clinical characteristic | NPI-Q = 0 (n = 48) | NPI-Q > 0 (n = 39) | P value |
---|---|---|---|
Sex, female, n (%) | 34 (58.6) | 24 (41.4) | 0.360 |
Age, year, mean ± SD | 68.19 ± 8.01 | 71.82 ± 6.1 | 0.022 |
Years of education ± SD | 12.9 ± 2.3 | 12.1 ± 2.8 | 0.115 |
Cognitive function | |||
CDR, mean ± SD | 0.2 ± 0.3 | 0.4 ± 0.3 | < 0.001 |
CDR-SoB, mean ± SD | 0.34 ± 1.03 | 1.71 ± 2.04 | < 0.001 |
MMSE, ± SD | 28.4 ± 1.92 | 26.03 ± 3.44 | < 0.001 |
AD CSF biomarkers | |||
Aβ1–42, pg/ml, mean ± SD | 939.72 ± 235.74 | 725.32 ± 257.72 | < 0.001 |
Tau, pg/ml, mean ± SD | 240.08 ± 113.76 | 507.56 ± 354.85 | < 0.001 |
pTau181, pg/ml, mean ± SD | 50.96 ± 21.87 | 75.32 ± 47.42 | 0.002 |
pTau/Aβ ratio, mean ± SD | 0.06 ± 0.03 | 0.13 ± 0.12 | < 0.001 |
Biochemical measures | |||
ApoEε4, n (%ε4) | 8 (27.6) | 21 (72.4) | < 0.001 |
QAlb, mean ± SD | 5.02 ± 1.71 | 6.95 ± 2.62 | < 0.001 |
Neuropsychiatric status | |||
NPI score, mean ± SD | 0.0 ± 0.0 | 5.74 ± 5.26 | < 0.001 |